Our 8th Annual Access to Innovation conference is a full day event that brings together life sciences leaders from academia, research, health institutions, government, and industry to discuss emerging trends, innovation, economic impact, translational science, and policies to advance the sector. This year's event will resume in person.
The BC life sciences sector has never been stronger, leading the country in the pace of discovery and company creation. By leveraging our world-class research, we are well-positioned to deliver innovative product solutions and services critical to the health system while driving economic diversification and competitiveness.
As leaders, we need to seize the opportunity to significantly advance the sector and ensure that BC builds on the extraordinary momentum of the last few years by working together to develop policies and strategies that attract capital and talent and enable scale. The time for sustained collaborative action - between industry, research and academia, and government - is now.
Please join us as we dive into the most pressing issues facing the BC life sciences sector.
Confirmed Speakers:
Ali Ardakani, Founder & Managing Director, Novateur Ventures; Board Chair, Life Sciences BC
Paul Armitage, Partner, Gowling WLG
Dr. Julia Bickford, Regional Director, Research Evaluation and Analytics, Northern Health
Linda Buchanan, Chair, Invest Vancouver Management Board; Mayor, City of North Vancouver
Dr. Michael Chen, Clinical Pathologist, Department of Laboratory Medicine, Island Health; Adjunct Assistant Professor, University of British Columbia & University of Victoria
Lisa Chu, Dean, School of Health Sciences, British Columbia Institute of Technology
Abi Coman-Walker, COO, Acuitas Therapeutics
Stephen Filby, Founder & Principal Consultant, WestPAR Consultancy
Dr. Christine Genge, Associate Director, Global Talent Acquisition, STEMCELL Technologies
Dr. David Goodlett, Professor, University of Victoria; Director, University of Victoria-Genome BC Proteomics Centre
Dr. Fraser Hof, AVP Research, University of Victoria
Dr. Diana Ionescu, Clinical Professor, University of British Columbia; Consultant Pathologist, BC Cancer Agency
Dr. Tim Jacobs, Director, Molecular Design & Engineering, AbCellera
Dr. Shirin Kalyan, VP, Scientific Innovation, Qu Biologics
Dr. Barb Kinnaird, CEO, Response Biomedical
Dr. Darryl Knight, VP Research & Academic Affairs, Providence Health Care
Dr. Veronique Lecault, COO, AbCellera
Dr. Elicia Maine, Professor, Innovation & Entrepreneurship, and Associate VP, Knowledge Mobilization & Innovation, Simon Fraser University
Jennifer Marles, Partner, Oyen Wiggs
Dr. Murray McCutcheon, Senior VP Partnering, AbCellera
Dr. Robert McMaster, Vice Dean, Research & Professor, Department of Medical Genetics, University of British Columbia
Nathan Michaels, Director, Precision Medicine and Genetic Services, Ministry of Health
Alison Orth, Director, Clinical Trials BC, Michael Smith Health Research BC
Dr. Federica Di Palma, CSO & VP, Research and Innovation, Genome BC
Eric Petersson, Trade Commissioner, Pacific Regional Office, Global Affairs Canada
Darcia Pope, Chief Transformation Officer & Vice President, Innovation & Planetary Health, Vancouver Coastal Health
Andrea Sambati, President and CEO, Boehringer Ingelheim Canada
Angie Schick, Executive Director, New Ventures BC
Helen Sheridan, Chief Human Resources Officer, STEMCELL Technologies
Raymond Shih, Director, Data Products & Services, LifeLabs
Dr. Cynthia Shippam, Industry Technology Advisor, National Research Council Canada - IRAP
Dr. Ted Steiner, Professor, Medicine & Head of the Division of Infectious Diseases, University of British Columbia
Dr. Gavin C.E. Stuart, Professor, Department Obstetrics and Gynecology, University of British Columbia
Dr. James Taylor, Co-Founder, General Manager, Precision NanoSystems
Dr. Ali Tehrani, Venture Partner, Amplitude Ventures
Dr. Bryan Tennant, Scientific Director, Medical Affairs - Vaccines, GSK
Carlene Todd, VP Access, Roche
Laura Walsh, Senior Vice President, Philanthropy, VGH & UBC Hospital Foundation
Dr. Stephen Yip, Neuropathologist, Vancouver General Hospital; Medical Director of CGL/CCG, BC Cancer
With remarks from the Honourable Brenda Bailey, Minister of Jobs, Economic Development and Innovation, Government of British Columbia
Confirmed Session Themes:
Emerging Trends in the Talent Supply Chain
Evolving Access to Innovations in Precision Medicine
Increasing Access to Innovations for Patients Who Need Them: Moving Forward in Partnership
Engineering Next-Generation Immune Responses and Translation to Biomanufacturing
Innovations in Infection and Immunity
Less is More, the Future of mRNA Therapeutics Manufacturing
Leveraging Vaccine Research to Reimagine the Future
Licensing and Collaboration Agreements in the Life Sciences Sector
Navigating Government Support of IP Strategies
Remarks from LifeLabs
Unleashing the Potential of Clinical Trials in BC: A Vision Takes Shape
Life Sciences, Biotechnology, Biotech, Industry Association, Science
Profile Views:
36,230Company Profile Views
Company Overview
LifeSciences British Columbia is an industry-funded association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry.
All life sciences sectors, from biopharmaceuticals and medical devices, to bioproducts and bioenergy, forest, agricultural and marine biotech, are integrated into our organization and all that we do, ensuring that no life sciences sector is working in isolation — and that all sectors come together in a comprehensive, complementary and coordinated fashion.
Throughout the year, LifeSciences BC undertakes numerous programs and projects in support of these sectors. These include public policy initiatives, facilitating linkages between global industry and our local organizations, raising the profile of our industry internationally and thus facilitating investment and global partnering opportunities, and helping nurture economic development in British Columbia through the life sciences industry.
What does LifeSciences BC do?
Here are just a few of the activities LifeSciences BC carries out under our four strategic areas:
1. Active Facilitation of Investment and Partnering
LifeSciences BC connects our Members and Sponsors to global investors and strategic partners through several avenues including:
LifeSciences BC's on-line directory of companies, research institutions and technologies
Regular targeted strategic partnering events with top-tier multinationals
Co-producing of the annual BioPartnering North America, the largest stand-alone biopharma partnering event on the continent, and an event that regularly attracts delegates from over 25 countries
Our Life Sciences Ambassador Programme, whereby Members' and Sponsors' international business development objectives are supported by a seasoned LifeSciences BC executive on the ground in Europe. This representative is also connected to a global network of fellow Ambassadors in order to build the international partnerships companies are looking for.
Hosting of additional international conferences in British Columbia such as BIO's 2008 Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Regular hosting of incoming business and research delegations from around the world, and coordination of outgoing BC missions to leading international clusters
2. Advocacy and Public Policy Development
LifeSciences BC is regularly consulted by local, national and international bodies on a variety of issues related to science and technology, research and innovation. Through these consultations, we ensure that the BC life sciences industry has a voice at every table, and that voice is one of credible insight into not only the development of our local life sciences industry, but how science and technology affects the lives of everyone globally.
LifeSciences BC also proactively ensures that life sciences is a key priority on the agendas of our various levels of government, and positions the industry as a valuable partner in bettering our city, province and country. By working directly with government on a vast array of policy recommendations, we aim to create an environment which enables the successful execution of Members' and Sponsors' business development goals.
Following are just a few examples of our advocacy efforts and successes:
Development of our position paper, Building World-Class Biotech Businesses in BC — a blueprint for both government and industry to reach our full potential as a leading life sciences cluster
Formal submissions to key consultations such as the BC Conversation on Health and annual budget planning cycles
Leading role on the Pharmacare Taskforce, a collaboration between academia, industry and government whose twelve recommendations on BC's Pharmacare program were accepted in their entirety by the Provincial Government
Collaboration with the Provincial Government to gain approval for enhanced federal Intellectual Property and Data Protection
Introduction of changes to the provincial International Financial Activities Act to provide companies deriving income from life sciences patents tax savings of up to $8 million/year
3. Marketing and Promotion of our World-Class Science and Life Sciences Industry
LifeSciences BC actively works to raise the local, national and international profile of the companies and research institutions that make up British Columbia's life sciences industry. These efforts have led to major international exposure for Members and Sponsors, and subsequent investments and partnering deals. Below are some of the promotion vehicles we continually manage and utilize:
A coordinated strategic British Columbia presence at major international life science conferences such as BIO, BioPartnering Europe, The World Congress on Industrial Biotechnology, BioJapan and AusBiotech to name just a few
Production of the Annual LifeSciences BC Awards to recognize exceptional individuals and companies for their contributions to the industry, and to highlight to the local community, the importance of the life sciences sectors
A robust website that receives over 15,000 hits a month, and that acts as a central portal into all things life sciences in BC, including industry news and events, statistics and information, business development opportunities, resources, employment opportunities, and much more
Biolinks — LifeSciences BC's monthly electronic life sciences newsletter distributed globally to over 5,000 key contacts
4. Development and Support of our Human Capital Through Member Mentoring, Education and Networking
Through LifeSciences BC, Members and Sponsors are provided the opportunity to get informed on the latest issues affecting the industry, get connected to their peers, and get personal advice from industry leaders and experts. Following are just a few ways in which we enable this:
LifeSciences BC's BC Excels Mentorship Program for executives from emerging companies seeking to enhance their own professional development, and their company's product plan, commercialization and intellectual property protection strategies
Quarterly Breakfast Speaking Series featuring national and international industry leaders and local companies
Medical Device and BioProducts and BioEnergy Seminar Series to address topics of specific relevance to members from these sectors
Monthly Industry Roundtables on topics of relevance to all member sectors
Our Annual Salmon Barbeque — a networking event that every year brings together over 200 members of the broad life sciences community
Delivery of Biotech 101 — Biotechnology and Beyond: Introduction to the Life Sciences Industry two-day course for non-scientists
Delivery of the sanofi-aventis BioTalent Challenge — a science fair competition for high school students where they are mentored by a scientist from our community